Find comprehensive information on Cocaine Use Disorder (CUD), including clinical documentation, medical coding, and healthcare resources. This resource covers diagnosis criteria, treatment options, and support for cocaine addiction, cocaine dependence, and cocaine abuse. Learn about accurate diagnostic coding for CUD and best practices for healthcare professionals documenting cocaine-related disorders.
Also known as
Cocaine-related disorders
Covers various cocaine-induced disorders.
Cocaine-induced mental disorders
Mental disorders due to cocaine use.
Mental and behavioural disorders due to psychoactive substance use
Encompasses disorders from various substance use.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the cocaine use disorder currently active?
When to use each related code
| Description |
|---|
| Problematic cocaine use leading to significant impairment or distress. |
| Stimulant use disorder involving a stimulant other than cocaine (e.g., amphetamines). |
| Substance-induced psychosis arising from cocaine use. |
Coding F14.20 without specifying use pattern (continuous, episodic, in remission) leads to inaccurate severity and reimbursement.
Failing to code co-occurring mental health disorders (e.g., anxiety, depression) with cocaine use disorder impacts risk adjustment and care planning.
Miscoding cocaine intoxication (F14.129) as dependence (F14.20) can result in inaccurate clinical documentation and quality metrics.
Q: What are the most effective evidence-based interventions for severe cocaine use disorder in a clinical setting?
A: Severe cocaine use disorder often requires a multi-faceted approach incorporating evidence-based interventions like contingency management (CM), cognitive behavioral therapy (CBT), and motivational interviewing (MI). CM uses positive reinforcement to encourage abstinence, while CBT helps patients identify and modify triggers and drug-related thought patterns. MI addresses ambivalence and empowers patients to commit to change. Pharmacological interventions are currently limited, but research exploring medications like disulfiram and topiramate shows some promise. For severe cases, residential treatment programs can provide intensive, structured support and facilitate access to these therapies. Consider implementing a combination of these approaches tailored to the individual patient's needs and comorbidities. Explore how integrated treatment models can address co-occurring mental health disorders, which are common in individuals with severe cocaine use disorder.
Q: How can clinicians accurately differentiate cocaine withdrawal symptoms from other co-occurring psychiatric conditions during the diagnostic process?
A: Differentiating cocaine withdrawal symptoms from other psychiatric conditions requires a thorough clinical assessment, including a detailed patient history, mental status examination, and comprehensive review of substance use patterns. Cocaine withdrawal often presents with symptoms like fatigue, increased appetite, vivid and unpleasant dreams, psychomotor agitation or retardation, and intense cravings. These symptoms can overlap with those of depression, anxiety disorders, or other substance-induced withdrawal syndromes. Key differentiators include the temporal relationship between the last cocaine use and symptom onset, the specific constellation of symptoms exhibited, and the presence of physical signs like changes in heart rate and blood pressure. Accurate diagnosis requires careful consideration of the patient's complete clinical picture. Learn more about validated screening tools like the CAGE-AID and ASI-Lite to aid in substance use assessment and differential diagnosis. Explore how incorporating toxicology screening can enhance the accuracy of identifying cocaine use and ruling out other substances.
Patient presents with signs and symptoms consistent with Cocaine Use Disorder (CUD), also known as cocaine addiction, cocaine dependence, or cocaine abuse. Clinical indicators observed include craving for cocaine, loss of control over cocaine use, neglecting major role obligations at work, school, or home, and continued use despite significant social or interpersonal problems caused or exacerbated by the effects of cocaine. The patient reports spending a significant amount of time obtaining, using, or recovering from the effects of cocaine, indicating a disruption in their daily life. Physiological dependence is evident with reported withdrawal symptoms such as fatigue, increased appetite, vivid unpleasant dreams, sleep disturbances, psychomotor retardation or agitation. The patient's cocaine use has escalated over time, requiring larger amounts to achieve the desired effect, demonstrating tolerance. The patient meets the DSM-5 diagnostic criteria for Cocaine Use Disorder, severity to be determined based on the number of criteria met. Differential diagnoses considered include other stimulant use disorders, bipolar disorder, and anxiety disorders. Treatment plan will focus on evidence-based interventions including cognitive behavioral therapy (CBT), motivational interviewing, and contingency management. Referral to addiction specialist and support groups will be considered. Patient education on relapse prevention strategies and harm reduction will be provided. ICD-10 code F14.20 will be used for cocaine dependence, unspecified. Monitoring of treatment progress and ongoing assessment of cocaine use patterns will be documented in subsequent visits.